Corcept Therapeutics Incorporated (CORT)
NASDAQ · Healthcare
Corcept Therapeutics Incorporated Gross Profit 2009–2025
Corcept Therapeutics Incorporated annual/quarterly gross profit history and growth rate from 2016 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Corcept Therapeutics Incorporated gross profit for the quarter ending March 31, 2026 was 162.0 M, a 4.66% increase year-over-year.
- Corcept Therapeutics Incorporated gross profit for the twelve months ending March 31, 2026 was 710.9 M, a 17.08% increase year-over-year.
- Corcept Therapeutics Incorporated annual gross profit for 2025 was 748.4 M, a 12.69% increase from 2024.
- Corcept Therapeutics Incorporated annual gross profit for 2024 was 664.2 M, a 39.56% increase from 2023.
- Corcept Therapeutics Incorporated annual gross profit for 2023 was 475.9 M, a 20.03% increase from 2022.
- Corcept Therapeutics Incorporated annual gross profit for 2022 was 396.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Corcept Therapeutics Incorporated Gross Profit — FAQ
Corcept Therapeutics Incorporated (CORT) gross profit over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Corcept Therapeutics Incorporated's gross profit?
Corcept Therapeutics Incorporated (CORT) reported gross profit of $748M for fiscal 2025.
Where can I see CORT's gross profit history?
The chart and table above show Corcept Therapeutics Incorporated's gross profit by year and by quarter, including the growth rate.